
Charles River Laboratories International rose 97.5% from $173.50 to $342.69, ahead of the S&P 500's +9.8%. Its worst day was Mar 12 (−9.6%), and its low came May 18 at $149.93.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Charles River Laboratories International shares fell 8.9%, while the S&P 500 fell 1.2%.
−8.9% · S&P 500 −1.2%
EPS of $2.39 beat the $2.34 estimate on $994.2M revenue (est. $986.6M); FY revenue guidance of $4.0B–$4.1B against the $4.1B consensus.
Story events cover the past 12 months · Times ET
−0.3% · S&P 500 +0.5%
Charles River Laboratories International shares fell 9.6%, while the S&P 500 fell 1.5%.
−9.6%, the year's worst day · S&P 500 −1.5%
Charles River Laboratories International shares fell 9.2%, while the S&P 500 fell 0.4%.
−9.2% · S&P 500 −0.4%
EPS of $2.06 beat the $1.95 estimate on $995.8M revenue (est. $976.2M); FY revenue guidance of $3.8B–$3.9B against the $3.9B consensus.
0.0% · S&P 500 −0.3%
Charles River Laboratories International closed at its lowest level of the year, 13.6% below where the year started.
−0.6% · S&P 500 −0.1%
Charles River Laboratories International shares rose 10.2%, while the S&P 500 rose 0.6%.
+10.2% · S&P 500 +0.6%
EPS of $3.02 beat the $2.73 estimate on $1.0B revenue (est. $973.2M); FY revenue guidance of $3.9B–$3.9B against the $3.8B consensus.
+11.4%, the year's best day · S&P 500 −0.2%
Charles River Laboratories International shares rose 9.3%, while the S&P 500 rose 0.5%.
+9.3% · S&P 500 +0.5%
EPS of $3.09 beat the $2.97 estimate on $982.7M revenue (est. $959.6M); FY revenue guidance of $3.9B–$4.0B against the $3.9B consensus.
−7.3% · S&P 500 +1.7%
Where it ended: a close of $342.69 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 17, 2027 (EPS est. $3.30, revenue est. $971.4M).
Nothing in the past 12 months.
All CRL dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CRL and SPY from Benzinga historical bars. Not investment advice.